"Pulmonary and sleep specialists. Manage asthma, COPD, pulmonary hypertension, interstitial lung disease, pulmonary fibrosis, lung nodules, lung masses, pleural effusions, pneumonia , bronchitis, bronchiectasis, dyspraxia, trouble breathing, cough, chest pain."

During the past decade, Central Florida Pulmonary Group, PA conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 31 clinical trials were completed, i.e. on average, 54.4% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 23 clinical trials were completed. i.e. 85.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Florida Pulmonary Group, PA" #1 sponsor was "Vertex Pharmaceuticals Incorporated" with 15 trials, followed by "United Therapeutics" with 8 trials sponsored, "Actelion" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Proteostasis Therapeutics, Inc." with 4 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Florida Pulmonary Group, PA" #1 collaborator was "Cystic Fibrosis Foundation" with 3 trials as a collaborator, "Agility Clinical, Inc." with 1 trials as a collaborator, "Altavant Sciences, Inc." with 1 trials as a collaborator, "Canadian Heart Research Centre" with 1 trials as a collaborator and "Centers for Medicare and Medicaid Services" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Central Florida Pulmonary Group, PA" are "Cystic Fibrosis" (29 trials), "Idiopathic Pulmonary Fibrosis" (13 trials), "Pulmonary Arterial Hypertension" (10 trials), "Pulmonary Hypertension" (4 trials) and "Bronchiectasis" (3 trials). Many other conditions were trialed in "Central Florida Pulmonary Group, PA" in a lesser frequency.

Most popular intervention types in "Central Florida Pulmonary Group, PA" are "Drug" (67 trials), "Other" (5 trials), "Device" (4 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "IVA" (10 trials), "ELX/TEZ/IVA" (4 trials), "AZLI" (3 trials) and "Oral treprostinil" (3 trials). Other intervention names were less common.

The vast majority of trials in "Central Florida Pulmonary Group, PA" are 71 trials for "All" genders.

Currently, there are NaN active trials in "Central Florida Pulmonary Group, PA". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 44 completed trials in Central Florida Pulmonary Group, PA, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Central Florida Pulmonary Group, PA, 7 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".